Gene Symbol: SUMO-1
Description: small ubiquitin-like modifier 1
Alias: DAP1, GMP1, OFC10, PIC1, SENP2, SMT3, SMT3C, SMT3H3, UBL1, small ubiquitin-related modifier 1, GAP modifying protein 1, SMT3 homolog 3, SMT3 suppressor of mif two 3 homolog 1, sentrin, ubiquitin-homology domain protein PIC1, ubiquitin-like protein SMT3C, ubiquitin-like protein UBL1
Species: human
Products:     SUMO-1

Top Publications

  1. Collavin L, Gostissa M, Avolio F, Secco P, Ronchi A, Santoro C, et al. Modification of the erythroid transcription factor GATA-1 by SUMO-1. Proc Natl Acad Sci U S A. 2004;101:8870-5 pubmed
    ..These observations open interesting questions about the biological role of this posttranslational modification of GATA-1. ..
  2. Reverter D, Lima C. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature. 2005;435:687-92 pubmed
  3. Ivanov A, Peng H, Yurchenko V, Yap K, Negorev D, Schultz D, et al. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell. 2007;28:823-37 pubmed
    ..These data provide a mechanistic explanation for the cooperation of PHD and bromodomains in gene regulation and describe a function of the PHD domain as an intramolecular E3 SUMO ligase. ..
  4. Yurchenko V, Xue Z, Sadofsky M. SUMO modification of human XRCC4 regulates its localization and function in DNA double-strand break repair. Mol Cell Biol. 2006;26:1786-94 pubmed
    ..The modification may serve a regulatory role. Our finding fits with an emerging literature associating SUMO modification with the control of the repair and recombination associated with DNA breaks. ..
  5. Mooney S, Grande J, Salisbury J, Janknecht R. Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry. 2010;49:1-10 pubmed publisher
    ..In conclusion, sumoylation exerts pleiotropic effects on p68/p72, which may have important implications in breast cancer by modulating estrogen receptor and p53 activity. ..
  6. Gareau J, Reverter D, Lima C. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2. J Biol Chem. 2012;287:4740-51 pubmed publisher
  7. Mukhopadhyay D, Ayaydin F, Kolli N, Tan S, Anan T, Kametaka A, et al. SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J Cell Biol. 2006;174:939-49 pubmed
    Small ubiquitin-related modifier (SUMO) processing and deconjugation are mediated by sentrin-specific proteases/ubiquitin-like proteases (SENP/Ulps)...
  8. Wang J, Zhang H, Iyer D, Feng X, Schwartz R. Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier. J Biol Chem. 2008;283:23235-43 pubmed publisher
    ..SUMO conjugation stabilized the formation of Nkx2.5-containing complexes that led to robust transcriptional activation. Thus, SUMO modification serves as a positive regulator for Nkx2.5 transcriptional activity. ..
  9. Garee J, Meyer R, Oesterreich S. Co-repressor activity of scaffold attachment factor B1 requires sumoylation. Biochem Biophys Res Commun. 2011;408:516-22 pubmed publisher
    ..In summary, the transcriptional repressor SAFB1 is modified by both SUMO1 and SUMO2/3, and this modification is necessary for its full repressive activity. ..

More Information

Publications133 found, 100 shown here

  1. Quimby B, Yong Gonzalez V, Anan T, Strunnikov A, Dasso M. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast. Oncogene. 2006;25:2999-3005 pubmed
    ..These findings point toward a potential function of PML and PML:RARalpha as SUMO E3 enzymes or E3 regulators, and suggest that fusion of RARalpha to PML may affect this activity. ..
  2. Mabb A, Wuerzberger Davis S, Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol. 2006;8:986-93 pubmed
    ..Our findings demonstrate that PIASy is the first SUMO ligase for NEMO whose substrate specificity seems to be controlled by IKK interaction, subcellular targeting and oxidative stress conditions. ..
  3. Fernández Miranda G, Pérez de Castro I, Carmena M, Aguirre Portolés C, Ruchaud S, Fant X, et al. SUMOylation modulates the function of Aurora-B kinase. J Cell Sci. 2010;123:2823-33 pubmed publisher
    ..These data suggest that SUMOylation of Aurora B modulates its function, possibly by mediating the extraction of CPC complexes from chromosome arms during prometaphase. ..
  4. Galisson F, Mahrouche L, Courcelles M, Bonneil E, Meloche S, Chelbi Alix M, et al. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics. 2011;10:M110.004796 pubmed publisher
  5. Kubota Y, O Grady P, Saito H, Takekawa M. Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation. Nat Cell Biol. 2011;13:282-91 pubmed publisher
    ..Thus, oncogenic Ras efficiently activates the ERK pathway both by activating Raf and by inhibiting MEK SUMOylation, thereby inducing carcinogenesis. ..
  6. Ayaydin F, Dasso M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell. 2004;15:5208-18 pubmed
  7. Yang S, Galanis A, Witty J, Sharrocks A. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 2006;25:5083-93 pubmed
    ..We demonstrate that this extended motif can be used to correctly predict novel targets for SUMO modification. ..
  8. Percherancier Y, Germain Desprez D, Galisson F, Mascle X, Dianoux L, Estephan P, et al. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells. J Biol Chem. 2009;284:16595-608 pubmed publisher
  9. Riley B, Zoghbi H, Orr H. SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal. J Biol Chem. 2005;280:21942-8 pubmed
    ..Lys(16), Lys(194) preceding the polyglutamine tract, Lys(610)/Lys(697) in the C-terminal ataxin high mobility group domain, and Lys(746) all contribute to ataxin-1 SUMOylation. ..
  10. Dai X, Kolic J, Marchi P, Sipione S, MacDonald P. SUMOylation regulates Kv2.1 and modulates pancreatic beta-cell excitability. J Cell Sci. 2009;122:775-9 pubmed publisher
    ..Thus, protein SUMOylation can exert a strong inhibitory action on the voltage-dependent K(+) channel Kv2.1 and can regulate cellular excitability in native beta-cells. ..
  11. Cuchet Louren o D, Vanni E, Glass M, Orr A, Everett R. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol. 2012;86:11209-22 pubmed publisher
    ..I. We conclude that the ICP0-PML.I interaction reflects a countermeasure to PML-related antiviral restriction...
  12. Bailey D, O Hare P. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling. Biochem J. 2005;392:271-81 pubmed
    ..Taken together with other recent reports on the proteasome and PML NBs, these results suggest that the PML NBs may play an important role in integrating these pathways. ..
  13. Smet Nocca C, Wieruszeski J, Leger H, Eilebrecht S, Benecke A. SUMO-1 regulates the conformational dynamics of thymine-DNA Glycosylase regulatory domain and competes with its DNA binding activity. BMC Biochem. 2011;12:4 pubmed publisher
    ..This mechanism might be a general feature of SUMO-1 regulation of other DNA-bound factors such as transcription regulatory proteins. ..
  14. Matafora V, D Amato A, Mori S, Blasi F, Bachi A. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol Cell Proteomics. 2009;8:2243-55 pubmed publisher
    ..The analysis of the nature of the SUMO-1 targets identified in this study strongly indicates that sumoylation, acting in coordination with the ubiquitin-proteasome system, regulates the maintenance of nucleolar integrity. ..
  15. Hakli M, Karvonen U, Janne O, Palvimo J. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies. Exp Cell Res. 2005;304:224-33 pubmed
    ..In sum, we have identified SNURF as a novel component in PML bodies and suggest that SUMO-1-facilitated sequestration into these nuclear domains regulates the transcriptional activity of SNURF. ..
  16. Desterro J, Keegan L, Jaffray E, Hay R, O Connell M, Carmo Fonseca M. SUMO-1 modification alters ADAR1 editing activity. Mol Biol Cell. 2005;16:5115-26 pubmed
    ..Moreover, modification of wild-type recombinant ADAR1 by SUMO-1 reduces the editing activity of the enzyme in vitro. Taken together these data suggest a novel role for sumoylation in regulating RNA-editing activity. ..
  17. Zhao X, Sternsdorf T, Bolger T, Evans R, Yao T. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol. 2005;25:8456-64 pubmed
    ..Our studies reveal a novel regulation of MEF2 transcriptional activity by two distinct classes of deacetylases that affect MEF2 sumoylation and acetylation. ..
  18. Gong L, Yeh E. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem. 2006;281:15869-77 pubmed
    SUMOylation is a reversible process regulated by a family of sentrin/SUMO-specific proteases (SENPs). Of the six SENP family members, except for SENP1 and SENP2, the substrate specificities of the rest of SENPs are not well defined...
  19. Tatham M, Kim S, Jaffray E, Song J, Chen Y, Hay R. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol. 2005;12:67-74 pubmed
    ..Thus we show that E2-E3 interactions are not conserved across the ubiquitin-like protein superfamily and identify a RanBP2-dependent mechanism for SUMO paralog-specific conjugation. ..
  20. Pan Y, Chen J. Modification of MDMX by sumoylation. Biochem Biophys Res Commun. 2005;332:702-9 pubmed
    ..Therefore, sumoylation is not required for several activities of MDMX under our assay conditions. ..
  21. Li S, Wang M, Ao X, Chang A, Yang C, Zhao F, et al. CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-?. Oncogene. 2013;32:4883-91 pubmed publisher
  22. Lin D, Fang H, Ma A, Huang Y, Pu Y, Jenster G, et al. Negative modulation of androgen receptor transcriptional activity by Daxx. Mol Cell Biol. 2004;24:10529-41 pubmed
    ..Together, these findings not only provide a novel role of Daxx in controlling AR transactivation activity but also uncover the mechanism underlying sumoylation-dependent transcriptional repression of the AR. ..
  23. El McHichi B, Regad T, Maroui M, Rodriguez M, Aminev A, Gerbaud S, et al. SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol. 2010;84:11634-45 pubmed publisher
    ..Together, these findings reveal a new mechanism evolved by EMCV to antagonize the PML pathway in the interferon-induced antiviral defense. ..
  24. Shen L, Dong C, Liu H, Naismith J, Hay R. The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem J. 2006;397:279-88 pubmed
    The SUMO (small ubiquitin-like modifier)-specific protease SENP1 (sentrin-specific protease 1) can process the three forms of SUMO to their mature forms and deconjugate SUMO from modified substrates...
  25. Morris J, Boutell C, Keppler M, Densham R, Weekes D, Alamshah A, et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature. 2009;462:886-90 pubmed publisher
    ..These data demonstrate that the SUMOylation pathway plays a significant role in mammalian DNA damage response. ..
  26. Saether T, Pattabiraman D, Alm Kristiansen A, Vogt Kielland L, Gonda T, Gabrielsen O. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability. Oncogene. 2011;30:212-22 pubmed publisher
    ..This establishes SUMO binding as a mechanism involved in modulating the transactivation activity of c-Myb, and responsible for keeping the transforming potential of the oncoprotein in check. ..
  27. Escobar Cabrera E, Okon M, Lau D, Dart C, Bonvin A, McIntosh L. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX. J Biol Chem. 2011;286:19816-29 pubmed publisher
    ..These results provide insights into the binding mechanisms and hence biological roles of the DAXX SUMO-interacting motifs. ..
  28. Martin S, Tatham M, Hay R, Samuel I. Quantitative analysis of multi-protein interactions using FRET: application to the SUMO pathway. Protein Sci. 2008;17:777-84 pubmed publisher
    ..These assays provide powerful tools for the study of competitive biochemical cascades and the extent to which drug candidates modify protein interactions. ..
  29. Mohideen F, Capili A, Bilimoria P, Yamada T, Bonni A, Lima C. A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9. Nat Struct Mol Biol. 2009;16:945-52 pubmed publisher
    ..These data support an E2-dependent mechanism that underlies phosphorylation-dependent SUMO conjugation in pathways that range from the heat-shock response to nuclear hormone signaling to brain development. ..
  30. Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, Zhang X, et al. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. EMBO J. 2009;28:3534-48 pubmed publisher
    ..These results, thus, point to a novel mechanism for regulating PARP-1 transcription function, and suggest crosstalk between sumoylation and RNF4-mediated ubiquitination in regulating gene expression in response to heat shock. ..
  31. Cai Q, Verma S, Kumar P, Ma M, Robertson E. Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS ONE. 2010;5:e9720 pubmed publisher
    ..Knockdown of PIASy by small interfering RNA leads to reduction of VHL oligomerization and increases HIF1alpha degradation. These findings reveal a unique molecular strategy for inactivation of VHL under hypoxic stress. ..
  32. Fu J, Xiong Y, Xu Y, Cheng G, Tang H. MDA5 is SUMOylated by PIAS2? in the upregulation of type I interferon signaling. Mol Immunol. 2011;48:415-22 pubmed publisher
    ..Collectively, these findings suggest that SUMO-1 modification of MDA5 possibly via PIAS2? may play a role in the MDA5-mediated IFN response to viral infections. ..
  33. Lois L, Lima C. Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1. EMBO J. 2005;24:439-51 pubmed
    ..A mechanism for E2 recruitment to E1 is suggested by biochemical and genetic data, each of which supports a direct role for the E1 C-terminal ubiquitin-like domain for E2 recruitment during conjugation. ..
  34. Wei F, Scholer H, Atchison M. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem. 2007;282:21551-60 pubmed
    ..Therefore, sumoylation of Oct4 results in increased stability, DNA binding, and transactivation and provides an important mechanism to regulate Oct4 activity. ..
  35. Costa M, Lee S, Furtado M, Xin L, Sparrow D, Martinez C, et al. Complex SUMO-1 regulation of cardiac transcription factor Nkx2-5. PLoS ONE. 2011;6:e24812 pubmed publisher
    ..We also observe SUMOylation of Nkx2-5 cofactors, which may be critical to Nkx2-5 regulation. Our data reveal highly complex regulatory mechanisms driven by SUMOylation to modulate Nkx2-5 activity. ..
  36. Aillet F, Lopitz Otsoa F, Egaña I, Hjerpe R, Fraser P, Hay R, et al. Heterologous SUMO-2/3-ubiquitin chains optimize I?B? degradation and NF-?B activity. PLoS ONE. 2012;7:e51672 pubmed publisher
    ..Thus, hybrid SUMO-2/3-ubiquitin chains increase the susceptibility of modified I?B? to the action of 26S proteasome, contributing to the optimal control of NF-?B activity after TNF?-stimulation. ..
  37. Liu X, Liu Z, Jang S, Ma Z, Shinmura K, Kang S, et al. Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc Natl Acad Sci U S A. 2007;104:9679-84 pubmed
    ..Surprisingly, K230R mutant strongly binds to phosphatidylinositol-3,4,5-trisphosphate and suppresses DNA fragmentation. Thus, B23 sumoylation regulates its subcellular localization, cell proliferation, and survival activities. ..
  38. Plant L, Dementieva I, Kollewe A, Olikara S, Marks J, Goldstein S. One SUMO is sufficient to silence the dimeric potassium channel K2P1. Proc Natl Acad Sci U S A. 2010;107:10743-8 pubmed publisher
    ..Although channels engineered with one Lys274 site carry just one SUMO1 they are activated and silenced by SENP1 and SUMO1 like wild-type channels. ..
  39. Burrage P, Schmucker A, Ren Y, Sporn M, Brinckerhoff C. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression. Arthritis Res Ther. 2008;10:R139 pubmed publisher
    ..We conclude that the efficacy of combined treatment with lower doses of each drug may minimize potential side effects of treatment with these compounds. ..
  40. Keusekotten K, Bade V, Meyer Teschendorf K, Sriramachandran A, Fischer Schrader K, Krause A, et al. Multivalent interactions of the SUMO-interaction motifs in RING finger protein 4 determine the specificity for chains of the SUMO. Biochem J. 2014;457:207-14 pubmed publisher
    ..In the present paper, we describe that the sequence and spacing of the SIMs (SUMO-interaction motifs) in RNF4 regulate the avidity-driven recognition of substrate proteins carrying SUMO chains of variable length. ..
  41. Rosas Acosta G, Russell W, Deyrieux A, Russell D, Wilson V. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics. 2005;4:56-72 pubmed
  42. Vertegaal A, Andersen J, Ogg S, Hay R, Mann M, Lamond A. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics. 2006;5:2298-310 pubmed
  43. Lee J, Lee Y, Lee M, Park E, Kang S, Chung C, et al. Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex. Mol Cell Biol. 2008;28:6056-65 pubmed publisher
    ..These results indicate that dual modification of BMAL1 by SUMO2/3 and ubiquitin is essential for circadian activation and degradation of the CLOCK/BMAL1 complex. ..
  44. Vigodner M, Ishikawa T, Schlegel P, Morris P. SUMO-1, human male germ cell development, and the androgen receptor in the testis of men with normal and abnormal spermatogenesis. Am J Physiol Endocrinol Metab. 2006;290:E1022-33 pubmed
    ..Our data suggest that human testicular SUMO-1 has specific functions in heterochromatin organization, meiotic centromere function, and gene expression. ..
  45. Guzzo C, Berndsen C, Zhu J, Gupta V, Datta A, Greenberg R, et al. RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage. Sci Signal. 2012;5:ra88 pubmed publisher
    ..Our findings, therefore, connect ubiquitin- and SUMO-dependent DSB recognition, revealing that RNF4-synthesized hybrid SUMO-ubiquitin chains are recognized by RAP80 to promote BRCA1 recruitment and DNA repair. ..
  46. Matic I, van Hagen M, Schimmel J, Macek B, Ogg S, Tatham M, et al. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics. 2008;7:132-44 pubmed publisher
    ..The developed methodology is generic and can be adapted for the identification of other sumoylation sites in complex samples. ..
  47. Boggio R, Colombo R, Hay R, Draetta G, Chiocca S. A mechanism for inhibiting the SUMO pathway. Mol Cell. 2004;16:549-61 pubmed
    ..They also point out once again to the extraordinary ability of eukaryotic viruses to interfere with the biology of host cells by targeting fundamental biochemical processes. ..
  48. Lin D, Huang Y, Jeng J, Kuo H, Chang C, Chao T, et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell. 2006;24:341-54 pubmed
    ..Our results provide mechanistic insights into Daxx in SUMO-dependent transcriptional control and subnuclear compartmentalization. ..
  49. Braschi E, Zunino R, McBride H. MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep. 2009;10:748-54 pubmed publisher
    ..Importantly, the large number of unidentified mitochondrial SUMO targets suggests a global role for SUMOylation in mitochondrial function, placing MAPL as a crucial component in the regulation of multiple conjugation events. ..
  50. Sung K, Go Y, Ahn J, Kim Y, Kim Y, Choi C. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation. FEBS Lett. 2005;579:3001-8 pubmed
    ..These results suggest that phosphorylation-dependent sumoylation enables HIPK2 to drive different target gene transcription by means of differential interactions with its binding partners. ..
  51. Kuo M, den Besten W, Thomas M, Sherr C. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. Cell Cycle. 2008;7:3378-87 pubmed
  52. Janer A, Werner A, Takahashi Fujigasaki J, Daret A, Fujigasaki H, Takada K, et al. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7. Hum Mol Genet. 2010;19:181-95 pubmed publisher
    ..Our results demonstrate an influence of SUMOylation on the multistep aggregation process of ATXN7 and implicate a role for ATXN7 SUMOylation in SCA7 pathogenesis...
  53. Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene. 2011;30:1108-16 pubmed publisher
    ..Given the large number of TRIM proteins, our results may greatly expand the identified SUMO E3s. Furthermore, TRIM E3 activity may be an important contributor to SUMOylation specificity and the versatile functions of TRIM proteins. ..
  54. Moldovan G, Dejsuphong D, Petalcorin M, Hofmann K, Takeda S, Boulton S, et al. Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol Cell. 2012;45:75-86 pubmed publisher
    ..Thus, we propose that PARI is a long sought-after factor that suppresses inappropriate recombination events at mammalian replication forks...
  55. Ohbayashi N, Kawakami S, Muromoto R, Togi S, Ikeda O, Kamitani S, et al. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction. Biochem Biophys Res Commun. 2008;371:823-8 pubmed publisher
    ..These results indicate that the IL-6 family of cytokines modulates STAT3 activation by desumoylation and inactivation PML through SENP1 induction. ..
  56. MacPherson M, Beatty L, Zhou W, Du M, Sadowski P. The CTCF insulator protein is posttranslationally modified by SUMO. Mol Cell Biol. 2009;29:714-25 pubmed publisher
    ..These studies expand the repertoire of posttranslational modifications of CTCF and suggest roles for such modifications in its regulation of epigenetic states. ..
  57. Cuchet Lourenço D, Boutell C, Lukashchuk V, Grant K, Sykes A, Murray J, et al. SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes. PLoS Pathog. 2011;7:e1002123 pubmed publisher
    ..We conclude that recruitment of ND10 components to sites associated with HSV-1 genomes reflects a cellular defence against invading pathogen DNA that is regulated through the SUMO modification pathway. ..
  58. Yang M, Hsu C, Ting C, Liu L, Hwang J. Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J Biol Chem. 2006;281:8264-74 pubmed
    ..These results offer new insight into hTOP1 polysumoylation in response to TOP1-mediated DNA damage and may have general implications in protein polysumoylation. ..
  59. Guo B, Sharrocks A. Extracellular signal-regulated kinase mitogen-activated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3. Mol Cell Biol. 2009;29:3204-18 pubmed publisher
  60. Brunet Simioni M, de Thonel A, Hammann A, Joly A, Bossis G, Fourmaux E, et al. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene. 2009;28:3332-44 pubmed publisher
    ..As we also show that HSP27 binds to the SUMO-E2-conjugating enzyme, Ubc9, our study raises the possibility that HSP27 may act as a SUMO-E3 ligase specific for SUMO-2/3. ..
  61. Castillo Lluva S, Tatham M, Jones R, Jaffray E, Edmondson R, Hay R, et al. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat Cell Biol. 2010;12:1078-85 pubmed publisher
    ..The finding that a Ras superfamily member can be SUMOylated provides an insight into the regulation of these critical mediators of cell behaviour. Our data reveal a role for SUMO in the regulation of cell migration and invasion. ..
  62. Hong Y, Xing X, Li S, Bi H, Yang C, Zhao F, et al. SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS ONE. 2011;6:e23046 pubmed publisher
    ..These findings suggested that posttranslational modification of DEC1 in the form of SUMOylation may serve as a key factor that regulates the function of DEC1 in vivo. ..
  63. Shalizi A, Gaudilliere B, Yuan Z, Stegmuller J, Shirogane T, Ge Q, et al. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science. 2006;311:1012-7 pubmed
    ..Our findings define a mechanism underlying postsynaptic differentiation that may modulate activity-dependent synapse development and plasticity in the brain. ..
  64. Shen T, Lin H, Scaglioni P, Yung T, Pandolfi P. The mechanisms of PML-nuclear body formation. Mol Cell. 2006;24:331-9 pubmed
  65. Knipscheer P, van Dijk W, Olsen J, Mann M, Sixma T. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J. 2007;26:2797-807 pubmed
    ..Structural comparison suggests a model for poly-sumoylation involving a mechanism analogous to Mms2-Ubc13-mediated ubiquitin chain formation. ..
  66. Goodarzi A, Kurka T, Jeggo P. KAP-1 phosphorylation regulates CHD3 nucleosome remodeling during the DNA double-strand break response. Nat Struct Mol Biol. 2011;18:831-9 pubmed publisher
    ..We demonstrate that KAP-1(Ser824) phosphorylation generates a motif that directly perturbs interactions between CHD3's SUMO-interacting motif and SUMO1, dispersing CHD3 from heterochromatin DSBs and enabling repair. ..
  67. Yin Y, Seifert A, Chua J, Maure J, Golebiowski F, Hay R. SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 2012;26:1196-208 pubmed publisher
    ..Thus, RNF4 is a novel DNA damage-responsive protein that plays a role in homologous recombination and integrates SUMO modification and ubiquitin signaling in the cellular response to genotoxic stress. ..
  68. Gurer C, Berthoux L, Luban J. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol. 2005;79:910-7 pubmed
    ..HIV-1 bearing the p6-K27R mutation was insensitive to SUMO-1 overexpression, suggesting that covalent attachment of SUMO-1 to p6 is detrimental to HIV-1 replication. ..
  69. Shen L, Tang J, Tang B, Jiang H, Zhao G, Xia K, et al. Research on screening and identification of proteins interacting with ataxin-3. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005;22:242-7 pubmed
  70. Cheng T, Chang L, Howng S, Lu P, Lee C, Hong Y. SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization. Life Sci. 2006;78:1114-20 pubmed
  71. Dorval V, Fraser P. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem. 2006;281:9919-24 pubmed
    ..These findings revealed a new, possibly regulatory, modification of tau and alpha-synuclein that may also have implications for their pathogenic roles in neurodegenerative diseases. ..
  72. Riquelme C, Barthel K, Liu X. SUMO-1 modification of MEF2A regulates its transcriptional activity. J Cell Mol Med. 2006;10:132-44 pubmed
    ..Our results suggest that protein sumoylation could play a pivotal role in controlling MEF2 transcriptional activity. ..
  73. Mohan R, Rao A, Gagliardi J, Tini M. SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment. Mol Cell Biol. 2007;27:229-43 pubmed
    ..These findings suggest that TDG sumoylation promotes intramolecular interactions with amino- and carboxy-terminal SUMO-1 binding motifs that dramatically alter the biochemical properties and subcellular localization of TDG. ..
  74. Tsuruzoe S, Ishihara K, Uchimura Y, Watanabe S, Sekita Y, Aoto T, et al. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun. 2006;351:920-6 pubmed
    ..These indicate that Sox2 sumoylation negatively regulates its transcriptional role through impairing the DNA binding. ..
  75. Liu Q, Li J, Khoury J, Colgan S, Ibla J. Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem. 2009;284:13686-95 pubmed publisher
    ..In summary, we present an endogenous mechanism by which cells and tissues acquire anti-inflammatory properties by recruiting a nondegradable form of IkappaBalpha, a major control point for NFkappaB activation via Ado signaling. ..
  76. Tseng C, Cheng T, Shu C, Jeng K, Lai M. Modification of small hepatitis delta virus antigen by SUMO protein. J Virol. 2010;84:918-27 pubmed publisher
    ..Sumoylation represents a new type of modification for HDAg...
  77. Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller K, Jackson S. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature. 2009;462:935-9 pubmed publisher
    ..These findings thus identify PIAS1 and PIAS4 as components of the DDR and reveal how protein recruitment to DSB sites is controlled by coordinated SUMOylation and ubiquitylation. ..
  78. Olsen S, Capili A, Lu X, Tan D, Lima C. Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature. 2010;463:906-12 pubmed publisher
    ..These changes displace side chains required for adenylation with side chains required for thioester bond formation. Mutational and biochemical analyses indicate these mechanisms are conserved in other E1s. ..
  79. Ribet D, Hamon M, Gouin E, Nahori M, Impens F, Neyret Kahn H, et al. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature. 2010;464:1192-5 pubmed publisher
    ..Together, our results reveal that Listeria, and probably other pathogens, dampen the host response by decreasing the SUMOylation level of proteins critical for infection. ..
  80. Du J, McConnell B, Yang V. A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Krüppel-like factor 4. J Biol Chem. 2010;285:28298-308 pubmed publisher
    ..These results, therefore, illustrate a novel mechanism by which SUMO interaction modulates the activity of transcription factors. ..
  81. Matic I, Schimmel J, Hendriks I, van Santen M, van de Rijke F, van Dam H, et al. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol Cell. 2010;39:641-52 pubmed publisher
    ..In 16 proteins we identified a hydrophobic cluster SUMOylation motif (HCSM). SUMO conjugation of RanGAP1 and ZBTB1 via HCSMs is remarkably efficient. ..
  82. Chang C, Naik M, Huang Y, Jeng J, Liao P, Kuo H, et al. Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. Mol Cell. 2011;42:62-74 pubmed publisher
    ..Our findings provide structural insights into the Daxx-SIM:SUMO-1 complex, a model of SIM phosphorylation-enhanced SUMO paralog-selective modification and interaction, and phosphorylation-regulated Daxx function in apoptosis. ..
  83. Bossis G, Malnou C, Farras R, Andermarcher E, Hipskind R, Rodriguez M, et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol. 2005;25:6964-79 pubmed
    ..This supports the idea that this modification does not constitute a final inactivation step that necessarily precedes protein degradation. ..
  84. Kunapuli P, Kasyapa C, Chin S, Caldas C, Cowell J. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML. Exp Cell Res. 2006;312:3739-51 pubmed
    ..Overall our results suggest that the sumoylation of ZNF198 is important for PML body formation and that the abrogation of sumoylation of ZNF198 in ZNF198/FGFR1 expressing cells may be an important mechanism in cellular transformation. ..
  85. Reverter D, Lima C. Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates. Nat Struct Mol Biol. 2006;13:1060-8 pubmed
    ..SUMO isoform processing and SUMO isoform interactions, X-ray structures were determined for a catalytically inert SENP2 protease domain in complex with conjugated RanGAP1-SUMO-1 or RanGAP1-SUMO-2, or in complex with SUMO-2 or SUMO-3 ..
  86. Tatham M, Geoffroy M, Shen L, Plechanovova A, Hattersley N, Jaffray E, et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol. 2008;10:538-46 pubmed publisher
    ..These results demonstrate that poly-SUMO chains can act as discrete signals from mono-SUMOylation, in this case targeting a poly-SUMOylated substrate for ubiquitin-mediated proteolysis. ..
  87. Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, et al. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol. 2009;16:133-40 pubmed publisher
  88. Luciani A, Villella V, Vasaturo A, Giardino I, Raia V, Pettoello Mantovani M, et al. SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol. 2009;183:2775-84 pubmed publisher
    ..Targeting TG2-SUMO interactions might represent a new option to control disease evolution in CF patients as well as in other chronic inflammatory diseases, neurodegenerative pathologies, and cancer. ..
  89. Boutell C, Cuchet Louren o D, Vanni E, Orr A, Glass M, McFarlane S, et al. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 2011;7:e1002245 pubmed publisher
    ..We conclude that ICP0 has dual targeting mechanisms involving both SUMO- and substrate-dependent targeting specificities in order to counteract intrinsic antiviral resistance to HSV-1 infection...
  90. Rabellino A, Carter B, Konstantinidou G, Wu S, Rimessi A, Byers L, et al. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer Res. 2012;72:2275-84 pubmed publisher
    ..Together, our findings reveal novel roles for PIAS1 and the SUMOylation machinery in regulating oncogenic networks and the response to leukemia therapy. ..
  91. Maroui M, Kheddache Atmane S, El Asmi F, Dianoux L, Aubry M, Chelbi Alix M. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms. PLoS ONE. 2012;7:e44949 pubmed publisher
  92. Sun H, Hunter T. Poly-small ubiquitin-like modifier (PolySUMO)-binding proteins identified through a string search. J Biol Chem. 2012;287:42071-83 pubmed publisher
    ..We suggest that the clustered SIMs in these proteins form distinct SUMO binding domains to recognize diverse forms of protein sumoylation. ..